Literature DB >> 20850816

Microvesicle induction of prostate specific gene expression in normal human bone marrow cells.

Joseph F Renzulli1, Michael Del Tatto, Gerri Dooner, Jason Aliotta, Lisa Goldstein, Mark Dooner, Gerald Colvin, Devasis Chatterjee, Peter Quesenberry.   

Abstract

PURPOSE: Transfer of genetic material from cancer cells to normal cells occurs via microvesicles. Cell specific phenotypes can be induced in normal cells by the transfer of material in microvesicles, leading to genetic changes. We report the identification and expression of prostate specific genes in normal human marrow cells co-cultured with human prostate cancer cells.
MATERIALS AND METHODS: We harvested prostate tissue from 11 patients with prostate cancer. In 4 cases prostate tissue was co-cultured across from human marrow for 2 or 7 days but separated from it by a 0.4 μM polystyrene membrane. In 5 cases conditioned medium from patient cancer tissue was collected and ultracentrifuged, and microvesicles were collected for co-culture (3) and vesicle characterization (3). Explanted human marrow was harvested from cultures and RNA extracted. Real-time reverse transcriptase-polymerase chain reaction was done for select prostate specific genes.
RESULTS: Marrow exposed to human prostate tumor or isolated microvesicles in culture in 4 and 3 cases, respectively, showed at least 2-fold or greater prostate gene expression than control marrow. In 1 case in which normal prostate was co-cultured there were no prostate gene increases in normal marrow.
CONCLUSIONS: Prostate cancer tumor cells co-cultured with human bone marrow cells induce prostate specific gene expression. The proposed mechanism of transfer of genetic material is via microvesicles. This represents an opportunity for novel therapeutic agents, such as antibodies, to block microvesicle release from cancer cells or for agents that may block cells from accepting microvesicles.
Copyright © 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20850816      PMCID: PMC4495658          DOI: 10.1016/j.juro.2010.06.119

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  28 in total

1.  Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.

Authors:  Kevin B Hotary; Edward D Allen; Peter C Brooks; Nabanita S Datta; Michael W Long; Stephen J Weiss
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

2.  Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery.

Authors:  J Ratajczak; K Miekus; M Kucia; J Zhang; R Reca; P Dvorak; M Z Ratajczak
Journal:  Leukemia       Date:  2006-05       Impact factor: 11.528

3.  Tissue factor-positive microparticles in blood associated with coagulopathy in cancer.

Authors:  Ursula Rauch; Silvio Antoniak
Journal:  Thromb Haemost       Date:  2007-01       Impact factor: 5.249

4.  Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.

Authors:  D F Carney; C H Hammer; M L Shin
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

5.  Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes.

Authors:  Monika Baj-Krzyworzeka; Rafał Szatanek; Kazimierz Weglarczyk; Jarosław Baran; Barbara Urbanowicz; Piotr Brański; Mariusz Z Ratajczak; Marek Zembala
Journal:  Cancer Immunol Immunother       Date:  2005-11-09       Impact factor: 6.968

6.  Proteomic analysis of microvesicles derived from human colorectal cancer cells.

Authors:  Dong-Sic Choi; Jae-Min Lee; Gun Wook Park; Hyeon-Woo Lim; Joo Young Bang; Yoon-Keun Kim; Kyung-Hoon Kwon; Ho Jeong Kwon; Kwang Pyo Kim; Yong Song Gho
Journal:  J Proteome Res       Date:  2007-10-24       Impact factor: 4.466

7.  The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness.

Authors:  A Ginestra; M D La Placa; F Saladino; D Cassarà; H Nagase; M L Vittorelli
Journal:  Anticancer Res       Date:  1998 Sep-Oct       Impact factor: 2.480

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  Complement inhibitor membrane cofactor protein (MCP; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form.

Authors:  Juha Hakulinen; Sami Junnikkala; Timo Sorsa; Seppo Meri
Journal:  Eur J Immunol       Date:  2004-09       Impact factor: 5.532

10.  Cells release prions in association with exosomes.

Authors:  Benoit Fevrier; Didier Vilette; Fabienne Archer; Damarys Loew; Wolfgang Faigle; Michel Vidal; Hubert Laude; Graça Raposo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

View more
  25 in total

1.  Progenitor/stem cell fate determination: interactive dynamics of cell cycle and microvesicles.

Authors:  Jason M Aliotta; David Lee; Napoleon Puente; Sam Faradyan; Edmund H Sears; Ashley Amaral; Laura Goldberg; Mark S Dooner; Mandy Pereira; Peter J Quesenberry
Journal:  Stem Cells Dev       Date:  2012-02-15       Impact factor: 3.272

2.  Tumor exosomes: a novel biomarker?

Authors:  Jason M Aliotta
Journal:  J Gastrointest Oncol       Date:  2011-12

3.  Cellular phenotype and extracellular vesicles: basic and clinical considerations.

Authors:  Peter J Quesenberry; Laura R Goldberg; Jason M Aliotta; Mark S Dooner; Mandy G Pereira; Sicheng Wen; Giovanni Camussi
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

Review 4.  Extracellular RNA mediates and marks cancer progression.

Authors:  Jasmina S Redzic; Leonora Balaj; Kristan E van der Vos; Xandra O Breakefield
Journal:  Semin Cancer Biol       Date:  2014-04-28       Impact factor: 15.707

Review 5.  Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles.

Authors:  Peter J Quesenberry; Mark S Dooner; Jason M Aliotta
Journal:  Exp Hematol       Date:  2010-04-09       Impact factor: 3.084

6.  Exosome/microvesicle-mediated epigenetic reprogramming of cells.

Authors:  Giovanni Camussi; Maria-Chiara Deregibus; Stefania Bruno; Cristina Grange; Valentina Fonsato; Ciro Tetta
Journal:  Am J Cancer Res       Date:  2010-10-22       Impact factor: 6.166

7.  Stable cell fate changes in marrow cells induced by lung-derived microvesicles.

Authors:  Jason M Aliotta; Mandy Pereira; Ming Li; Ashley Amaral; Arina Sorokina; Mark S Dooner; Edmund H Sears; Kate Brilliant; Bharat Ramratnam; Douglas C Hixson; Peter J Quesenberry
Journal:  J Extracell Vesicles       Date:  2012-04-16

8.  The emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy.

Authors:  Andrew J Tompkins; Devasis Chatterjee; Michael Maddox; Justin Wang; Emily Arciero; Giovanni Camussi; Peter J Quesenberry; Joseph F Renzulli
Journal:  J Extracell Vesicles       Date:  2015-06-30

Review 9.  Extracellular vesicles as an emerging mechanism of cell-to-cell communication.

Authors:  Ciro Tetta; Ezio Ghigo; Lorenzo Silengo; Maria Chiara Deregibus; Giovanni Camussi
Journal:  Endocrine       Date:  2012-12-01       Impact factor: 3.633

10.  Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells.

Authors:  Hillary E Mulvey; Audrey Chang; Jason Adler; Michael Del Tatto; Kimberly Perez; Peter J Quesenberry; Devasis Chatterjee
Journal:  BMC Cancer       Date:  2015-08-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.